skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
02/18/2020
Application #:
15312928
Filing Dt:
06/09/2017
Publication #:
Pub Dt:
10/26/2017
Inventors:
Wuyuan LU, Issac WITZ, Shelly MAMAN
Title:
TREATMENT OF CANCER AND INHIBITION OF METASTASIS USING HEMOGLOBIN BETA SUBUNIT
Assignment: 1
Reel/Frame:
046211/0704Recorded: 06/27/2018Pages: 2
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
06/15/2015
Assignee:
OFFICE OF RESEARCH AND DEVELOPMENT
620 W. LEXINGTON STREET, 4TH FLOOR
BALTIMORE, UNITED STATES 21201
Correspondent:
WENDEROTH, LIND & PONACK, L.L.P.
1030 15TH STREET, N.W., SUITE 400 EAST
WASHINGTON, DC 20005
Assignment: 2
Reel/Frame:
046211/0686Recorded: 06/27/2018Pages: 2
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
07/13/2015
Exec Dt:
07/13/2015
Assignee:
P.O. BOX 39296
TEL AVIV, ISRAEL 6139001
Correspondent:
WENDEROTH, LIND & PONACK, L.L.P.
1030 15TH STREET, N.W., SUITE 400 EAST
WASHINGTON, DC 20005
Assignment: 3
Reel/Frame:
040867/0796Recorded: 01/06/2017Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
01/04/2017
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980

Search Results as of: 04/27/2024 11:23 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT